“…The ABP was recently complemented by the inclusion of two serum steroid markers, that is, T and androst‐4‐ene‐3,17‐dione (Adione; A4), to further strengthen the ABPs capability of detecting the administration of endogenous AAS, especially in females 130 . The intraindividual stability of urinary steroid profiles was found to be less robust in female than in male athletes, 34 and despite the use of concentrations and concentration ratios of a variety of steroidal analytes such as T, epitestosterone (EpiT), androsterone (A), etiocholanolone (E), 5α‐androstane‐3α,17β‐diol (5αAdiol), and 5β‐androstane‐3α,17β‐diol (5βAdiol), several confounding factors as for instance time of day, in‐ versus out‐of‐competition sample collection, and hormonal contraception have been shown to affect urinary steroid profile data, 35 and consensus exists in the added value of serum steroid analyses in the context of sports drug testing 36 . Accounting for confounding factors in ABP result interpretations is vital and likewise is the optimization of analytical tests.…”